Category: AstraZeneca’s Cancer Drug Trial Disappoints

AstraZeneca’s Cancer Drug Trial Disappoints, Sending Shares Lower

  1. AstraZeneca’s Cancer Drug Trial Disappoints, Sending Shares Lower  New York Times
  2. AstraZeneca shares plunge 15 percent as lung cancer study fails  Reuters
  3. AstraZeneca’s Mystic cancer drug trial fails  MarketWatch
  4. Full coverage

from Business – Google News https://www.nytimes.com/2017/07/27/business/astrazeneca-mystic-share.html

Advertisements